2026-01-29 - Analysis Report
### Overview of UnitedHealth Group Inc. (UNH)
UnitedHealth Group Inc., a diversified health care company, offers health benefits and health services in the United States.

### Return Rate Comparison
|  | Cumulative Return |
| --- | --- |
| Review Stock (UNH) | 12.38% |
| Comparison Stock (VOO) | 128.51% |
| Divergence | -116.10 |

The review stock (UNH) has a cumulative return of 12.38%, while the comparison stock (VOO) has a cumulative return of 128.51%. The divergence is -116.10, indicating that the review stock has a significantly lower return compared to the comparison stock.

### Alpha, Beta Analysis
| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 47.0% | 18.6% | 38.0% | 0.9 | 234.4B |
| 2017-2019 | 40.0% | 19.3% | 15.0% | 0.9 | 276.6B |
| 2018-2020 | 26.0% | 34.8% | 2.0% | 1.1 | 329.9B |
| 2019-2021 | 82.0% | 34.8% | 17.0% | 1.1 | 472.4B |
| 2020-2022 | 82.0% | 34.8% | 78.0% | 0.9 | 498.8B |
| 2021-2023 | 46.0% | 15.8% | 28.0% | 0.5 | 495.3B |
| 2022-2024 | -23.0% | 21.6% | -52.0% | 0.4 | 475.9B |
| 2023-2025 | -89.0% | 59.3% | -164.0% | 0.3 | 310.6B |

The review stock has a high CAGR (Compound Annual Growth Rate) range from 40% to 82% across the different time periods, indicating high growth but with some volatility. The Beta range is 0.5-1.1, suggesting the stock is moderately volatile compared to the market.

### Recent Stock Price Fluctuations
|  | Close | Last-Market | 5-day SMA | 20-day SMA | 60-day SMA |
| --- | --- | --- | --- | --- | --- |
| 2026-01-28 | $282.70 | $293.545 | $338.56 | $338.09 | $331.43 |

The stock price has a 5-day SMA of $338.56, indicating a upward trend in the short term.

### RSI, PPO Analysis
| Indicator | Value | Interpretation |
| --- | --- | --- |
| RSI | 25.83 | Low (indicating potential oversold conditions) |
| PPO | -0.88 | Strong Sell (indicating potential price decline) |
| Expected Return | 3385.10% | High (indicating potential long-term performance) |

The RSI and PPO values indicate low and overbought conditions, respectively, suggesting possible corrections in the short term.

### Recent News & Significant Events

- [2026-01-27] UnitedHealth Group Stock Is Not Attractive Yet: Caution Is Warranted (NYSE:UNH) - Seeking Alpha
- [2026-01-28] UNH stock just did something to the Dow Jones you rarely see - thestreet.com
- [2026-01-27] UnitedHealth: Outlook Makes Shares Plunge (NYSE:UNH) - Seeking Alpha
- [2026-01-27] Stock Market Today: Dow Loses 400 Points As UnitedHealth Tumbles; S&P 500 Sets A Record (Live Coverage) - Investor's Business Daily
- [2026-01-28] Buffett Bet Big On UnitedHealth Stock In Q2 â€” Now Berkshire Hathaway Could Be Down Billions - Yahoo Finance

Recent news articles suggest a decline in the stock price, with potential concerns over the company's outlook.

### Analyst Opinions
- Analyst Consensus: Buy
- Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
- Opinions: 25
- Target Price (avg/high/low): $373.60 / $440.00 / $280.00

Analysts have a consensus buy opinion on UNH, with a target price range of $373.60 to $440.00.

### Recent Earnings Analysis
| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-28 | $2.59 | $113.16 B$ |
| 2025-08-11 | $3.76 | $111.62 B$ |
| 2025-05-07 | $6.9 | $109.58 B$ |
| 2024-11-04 | $6.56 | $100.82 B$ |
| 2025-10-28 | $6.56 | $100.82 B$ |

The earnings per share (EPS) has fluctuated between $2.59 and $6.9, while the revenue has ranged from $100.82 B to $113.16 B.

### Financial Information
#### Revenue and Profitability
| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $113.16B | 18.24% |
| 2025-06-30 | $111.62B | 17.93% |
| 2025-03-31 | $109.58B | 21.70% |
| 2024-12-31 | $100.81B | 21.14% |
| 2024-09-30 | $100.82B | 22.84% |

#### Capital and Profitability
| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

### Comprehensive Analysis (Summary of previous items)

Overall, the review of UNH stock indicates mixed performance across various metrics. The stock has a relatively low return compared to the market, but with a high growth potential indicated by the CAGR values. The recent news and analyst opinions suggest concerns over the company's outlook, which may impact the stock price in the short term.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.